Monika Baudler

1.1k total citations
24 papers, 384 citations indexed

About

Monika Baudler is a scholar working on Molecular Biology, Physiology and Economics and Econometrics. According to data from OpenAlex, Monika Baudler has authored 24 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Physiology and 7 papers in Economics and Econometrics. Recurrent topics in Monika Baudler's work include Alzheimer's disease research and treatments (11 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Statistical Methods in Clinical Trials (6 papers). Monika Baudler is often cited by papers focused on Alzheimer's disease research and treatments (11 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Statistical Methods in Clinical Trials (6 papers). Monika Baudler collaborates with scholars based in Switzerland, United Kingdom and Germany. Monika Baudler's co-authors include Rachelle S. Doody, Paul Delmar, Paulo Fontoura, Geoffrey A. Kerchner, Danielle Abi‐Saab, Gregory Klein, Carsten Hofmann, Nicola Voyle, Manfred Schartl and Joachim Altschmied and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Genome Research.

In The Last Decade

Monika Baudler

21 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monika Baudler Switzerland 8 195 149 86 59 48 24 384
Faisal Saeed United States 11 198 1.0× 300 2.0× 150 1.7× 23 0.4× 63 1.3× 27 566
Antônia Silva United States 6 355 1.8× 293 2.0× 83 1.0× 23 0.4× 55 1.1× 9 557
Ang Xing China 7 132 0.7× 118 0.8× 52 0.6× 20 0.3× 25 0.5× 10 321
Tina Loeffler Austria 9 251 1.3× 212 1.4× 47 0.5× 38 0.6× 23 0.5× 19 504
Stefania Ippati Italy 13 204 1.0× 148 1.0× 56 0.7× 22 0.4× 35 0.7× 20 399
Celia Fernandez United States 7 228 1.2× 238 1.6× 42 0.5× 16 0.3× 25 0.5× 7 482
Manasi Benurwar United Kingdom 9 505 2.6× 347 2.3× 170 2.0× 49 0.8× 119 2.5× 9 753
Cody L. Shults United States 8 162 0.8× 368 2.5× 45 0.5× 13 0.2× 55 1.1× 10 523
Ping‐Chung Chen United States 11 217 1.1× 400 2.7× 24 0.3× 46 0.8× 21 0.4× 13 600
Juliane Reiche Germany 8 379 1.9× 358 2.4× 59 0.7× 33 0.6× 29 0.6× 13 659

Countries citing papers authored by Monika Baudler

Since Specialization
Citations

This map shows the geographic impact of Monika Baudler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Baudler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Baudler more than expected).

Fields of papers citing papers by Monika Baudler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Baudler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Baudler. The network helps show where Monika Baudler may publish in the future.

Co-authorship network of co-authors of Monika Baudler

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Baudler. A scholar is included among the top collaborators of Monika Baudler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Baudler. Monika Baudler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boada, Merçé, Szofia Bullain, Tobias Bittner, et al.. (2024). Long-term safety of gantenerumab in participants with Alzheimer's disease: A phase III, open-label extension study (SCarlet RoAD). Journal of Alzheimer s Disease. 103(2). 528–541.
2.
3.
4.
5.
Boess, Frank, Christopher Lane, Marzia A. Scelsi, et al.. (2022). Baseline participant characteristics of GRADUATION: a study to evaluate once‐weekly subcutaneous administration of gantenerumab. Alzheimer s & Dementia. 18(S10). 1 indexed citations
6.
Klein, Gregory, Luc Bracoud, Derk D. Purcell, et al.. (2022). Comparing ARIA‐E severity scales and effects of treatment management thresholds. Alzheimer s & Dementia. 18(S5). 1 indexed citations
7.
Klein, Gregory, Paul Delmar, Geoffrey A. Kerchner, et al.. (2021). Thirty-Six-Month Amyloid Positron Emission Tomography Results Show Continued Reduction in Amyloid Burden with Subcutaneous Gantenerumab. The Journal of Prevention of Alzheimer s Disease. 8(1). 3–6. 44 indexed citations
8.
Klein, Gregory, Luc Bracoud, Derk D. Purcell, et al.. (2020). Calibration of a simplified ARIA‐E MRI severity scale suitable for clinical practice. Alzheimer s & Dementia. 16(S2). 3 indexed citations
9.
10.
Klein, Gregory, Paul Delmar, Nicola Voyle, et al.. (2019). Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis. Alzheimer s Research & Therapy. 11(1). 101–101. 158 indexed citations
11.
Klein, Gregory, Paul Delmar, Carsten Hofmann, et al.. (2018). Higher Dose Gantenerumab leads to Significant Reduction in Amyloid Plaque Burden -Results for the Marguerite and Scarlet Road Open Label Extension Studies (S2.005). Neurology. 90(15_supplement). 3 indexed citations
12.
Klein, Gregory, Paul Delmar, Carsten Hofmann, et al.. (2018). O1‐09‐03: 24‐MONTH AMYLOID PET RESULTS OF THE GANTENERUMAB HIGH‐DOSE OPEN LABEL EXTENSION STUDIES. Alzheimer s & Dementia. 14(7S_Part_4). 3 indexed citations
13.
Klein, Thomas, et al.. (2015). Expression of Prostacyclin‐Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In Vitro. Mediators of Inflammation. 2015(1). 9 indexed citations
14.
Gruber, Thomas, Natascha Hermann‐Kleiter, Christa Pfeifhofer‐Obermair, et al.. (2009). PKCθ cooperates with PKCα in alloimmune responses of T cells in vivo. Molecular Immunology. 46(10). 2071–2079. 40 indexed citations
15.
Klein, Thomas, et al.. (2008). Characterization of Eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo. Biochemical Pharmacology. 76(6). 717–725. 4 indexed citations
16.
Gekeler, Volker, Monika Baudler, Luba Benimetskaya, et al.. (2006). G3139 and Other CpG-Containing Immunostimulatory Phosphorothioate Oligodeoxynucleotides Are Potent Suppressors of the Growth of Human Tumor Xenografts in Nude Mice. Oligonucleotides. 16(1). 83–93. 36 indexed citations
17.
Baudler, Monika, Manfred Schartl, & Joachim Altschmied. (1999). Specific Activation of a STAT Family Member in Xiphophorus Melanoma Cells. Experimental Cell Research. 249(2). 212–220. 18 indexed citations
18.
Baudler, Monika, Jutta Duschl, Christoph Winkler, Manfred Schartl, & Joachim Altschmied. (1997). Activation of Transcription of the Melanoma Inducing Xmrk Oncogene by a GC Box Element. Journal of Biological Chemistry. 272(1). 131–137. 26 indexed citations
19.
Baudler, Monika, Jutta Duschl, Christoph Winkler, Manfred Schartl, & Joachim Altschmied. (1997). Activation of transcription of the melanoma inducing Xmrk oncogene by a GC box element.. Journal of Biological Chemistry. 272(11). 7565–7565. 1 indexed citations
20.
Altschmied, Joachim, I. Nanda, Ryan Kolb, et al.. (1996). The Xmrk oncogene promoter is derived from a novel amplified locus of unusual organization.. Genome Research. 6(2). 102–113. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Faisal Saeed Breakdown of academic impact, for papers by Antônia Silva Breakdown of academic impact, for papers by Ang Xing Breakdown of academic impact, for papers by Tina Loeffler Breakdown of academic impact, for papers by Stefania Ippati Breakdown of academic impact, for papers by Celia Fernandez Breakdown of academic impact, for papers by Manasi Benurwar Breakdown of academic impact, for papers by Cody L. Shults Breakdown of academic impact, for papers by Ping‐Chung Chen Breakdown of academic impact, for papers by Juliane Reiche
Rankless by CCL
2026